Navigation Links
NEI/FDA to hold 1-day glaucoma endpoints meeting
Date:7/27/2010

The National Eye Institute (NEI) and the Food and Drug Administration (FDA) are sponsoring a Glaucoma Endpoints conference on September 24, 2010, to develop definitions and standards for describing structural changes in the glaucomatous optic nerve and functional changes in vision, as criteria for approval of new glaucoma therapeutics in clinical trials. The one-day meeting will take place at the Natcher Center, National Institutes of Health in Bethesda, Md.

While functional measures of the presence and progression of glaucomatous optic neuropathy have been developed and are currently in use, they are imprecise and poorly resolved. Likewise, the precision, resolution and rate of change for structural parameters of the optic nerve head and retinal nerve fiber layer are also not yet well-articulated.

This meeting, part of an NEI/FDA series of Endpoints Symposia, will examine such non-IOP glaucoma endpoints. Participants will explore how to increase the precision of functional measures as well as better articulate the precision, resolution and rate of change for structural parameters of the optic nerve head and retinal nerve fiber layer. In addition, they will examine how best to compare and contrast such structural measures with functional outcomes in patients' vision.

Participants will also look at whether such functional and structural measures can be combined into new endpoints for glaucoma clinical trials to shorten the timeline for clinical trials/development of potential new therapies.

Faculty will include authorities in glaucoma and glaucoma diagnosis, including the newest structural and functional testing instruments and algorithms. FDA representatives will review current optic nerve endpoints used in glaucoma drug and device trials, while researchers will discuss in detail specific techniques and criteria as well as the relationships between structural events and functional outcomes.

Who should attend?

  • clinical researchers/basic scientists
  • glaucoma specialists
  • clinical trialists
  • pharmaceutical company representatives
  • glaucoma-related associations
  • biotech companies

The meeting is being managed by the Association for Research in Vision and Ophthalmology (AVRO). To download the full agenda, find a list of faculty and to register, visit www.arvo.org/endpoints010.


'/>"/>

Contact: Katrina Norfleet
knorfleet@arvo.org
240-221-2924
Association for Research in Vision and Ophthalmology
Source:Eurekalert

Related biology news :

1. Glaucomas unique protein expression could enhance diagnosis and treatment
2. New evidence that green tea may help fight glaucoma and other eye diseases
3. Genetic sleuth solves glaucoma mystery
4. AMP presents at FDA meeting on regulating diagnostics
5. AMP comments at FDA meeting on array-based tests
6. 55th annual meeting of the Health Physics Society
7. Genetics Society of America to host 2010 Yeast Genetics & Molecular Biology Meeting
8. Ecological Society of America explores global warming at its 95th Annual Meeting
9. 2010 Meeting of the Americas, Brazil: News media registration open
10. European Society of Human Reproduction and Embryology Annual Meeting
11. Meeting of ICES/CIEM experts in Bilbao on state of demersal fish populations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
(Date:5/9/2016)... UAE, May 9, 2016 Elevay ... comes to expanding freedom for high net worth professionals ... in today,s globally connected world, there is still no ... could ever duplicate sealing your deal with a firm ... passports by taking advantage of citizenship via investment programs ...
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and technical consulting, provides a free webinar on Performing Quality Investigations: ... 2016 at 12pm CT at no charge. , Incomplete investigations are still a ...
Breaking Biology Technology: